⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7314449 | 0.82 | — | — | |
| SCHEMBL12850774 | 0.71 | — | — | |
| SCHEMBL14401939 | 0.71 | — | — | |
| SCHEMBL2232793 | 0.71 | — | — | |
| SCHEMBL545598 | 0.71 | — | — | |
| SCHEMBL10660346 | 0.67 | — | — | |
| SCHEMBL2542626 | 0.65 | — | — | |
| SCHEMBL11942570 | 0.61 | — | — | |
| SCHEMBL1936947 | 0.61 | — | — | |
| SCHEMBL22093002 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111201226-B | Cyclic substituted imidazo [4,5-c ] quinoline derivatives | 辉瑞大药厂 | 2022-07-22 | — | — | CN | claimed |
| EP-3592740-B1 | CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES | PFIZER (US) | 2022-02-09 | — | — | EP | claimed |
| US-11161844-B2 | Cyclic substituted imidazo[4,5-c]quinoline derivatives | PFIZER INC. (US) | 2021-11-02 | — | — | US | claimed |
| CN-111201226-A | Cyclic substituted imidazo [4,5-c ] quinoline derivatives | 辉瑞大药厂 | 2020-05-26 | — | — | CN | claimed |
| US-20200039977-A1 | CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES | PFIZER (US) | 2020-02-06 | — | — | US | claimed |
| WO-2018163030-A1 | CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES | PFIZER INC. (US) | 2018-09-13 | — | — | WO | claimed |
| EP-2200440-B1 | ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS | CRESTONE INC (US) | 2017-07-19 | — | — | EP | claimed |
| EP-2091945-B1 | NOVEL INHIBITORS OF GLUTAMINYL CYCLASE | PROBIODRUG AG (DE) | 2014-01-15 | — | — | EP | claimed |
| US-8148380-B2 | Antibacterial amide and sulfonamide substituted heterocyclic urea compounds | CRESTONE, INC. (US) | 2012-04-03 | — | — | US | claimed |
| US-20120015941-A1 | Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds | CRESTONE, INC. (US) | 2012-01-19 | — | — | US | claimed |
| EP-2200440-A1 | ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS | Crestone, Inc. (US) | 2010-06-30 | — | — | EP | claimed |
| WO-2009015208-A1 | ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS | REPLIDYNE, INC. (US) | 2009-01-29 | — | — | WO | claimed |
| EP-0870780-B1 | Initiator system comprising an heterocyclic ligand for the anionic (co)polymerisation of (meth)acrylic monomers and polymerisation process using it | ATOFINA (FR) | 2004-09-15 | — | — | EP | claimed |
| EP-0870780-A1 | Initiator system comprising an heterocyclic ligand for the anionic (co)polymerisation of (meth)acrylic monomers and polymerisation process using it | ELF ATOCHEM S.A. (FR) | 1998-10-14 | — | — | EP | claimed |
| US-20240166661-A1 | Spiropiperidine Derivatives | CEPHALON LLC | 2024-05-23 | — | — | US | disclosed |
| US-20240166625-A1 | Substituted 4-Benzyl And 4-Benzoyl Piperidine Derivates | CEPHALON LLC | 2024-05-23 | — | — | US | disclosed |
| US-11931412-B2 | JAK1 inhibitors and uses thereof | WASHINGTON UNIVERSITY (US) | 2024-03-19 | — | — | US | disclosed |
| WO-1998049164-A1 | WRITABLE AND ERASABLE HIGH-DENSITY OPTICAL STORAGE MEDIA | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-11-05 | — | — | WO | disclosed |
| CN-1060469-A | Process for preparing cephalosporin derivatives | BEECHAM GROUP PLC (GB) | 1992-04-22 | — | — | CN | disclosed |
| US-4442267-A | SOLUTION OF ACRYLIC POLYMER IN ACRYLATE ESTER MONOMER | LOCTITE (IRELAND) LIMITED (IE) | 1984-04-10 | — | — | US | disclosed |